Clinical Trials Sponsored by Grifols Biologicals, LLC
Total 154 results
-
Grifols Biologicals, LLCActive, not recruitingVon Willebrand Disease
-
Grifols Biologicals, LLCActive, not recruitingAntithrombin III Deficiency
-
Grifols Biologicals, LLCCompletedSevere Hemophilia APoland
-
Grifols Biologicals, LLCCompleted
-
Grifols Therapeutics LLCGrifols Biologicals, LLCTerminatedHemophilia A, CongenitalUnited States, Spain, Italy, India, Canada, Russian Federation
-
Grifols Therapeutics LLCGrifols Biologicals, LLCCompletedAmyotrophic Lateral SclerosisUnited States
-
Instituto Grifols, S.A.CompletedVascular Surgical BleedingUnited States, Hungary, Russian Federation, Serbia
-
Instituto Grifols, S.A.Grifols Biologicals, LLCCompletedAlzheimer's DiseaseSpain, United States
-
Instituto Grifols, S.A.CompletedLiver Transplantation | Hepatitis BItaly
-
Instituto Grifols, S.A.CompletedImmune (Idiopathic) Thrombocytopenic PurpuraSpain, Russian Federation, United Kingdom
-
Instituto Grifols, S.A.Completed
-
Instituto Grifols, S.A.CompletedAmyotrophic Lateral SclerosisSpain
-
Instituto Grifols, S.A.Grifols Biologicals, LLCCompletedAlzheimer's DiseaseSpain, United States
-
Instituto Grifols, S.A.CompletedHemostasisUnited States
-
Grifols Biologicals, LLCInstituto Grifols, S.A.CompletedIdiopathic Thrombocytopenic PurpuraUnited States, India, Puerto Rico, Canada
-
Grifols Biologicals, LLCInstituto Grifols, S.A.CompletedSoft Tissue Surgical BleedingUnited States, Hungary, Serbia
-
Instituto Grifols, S.A.CompletedSafety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open SurgeriesParenchymous Tissue Surgical BleedingUnited States, Hungary, Russian Federation, Serbia
-
Instituto Grifols, S.A.CompletedPrimary Immune Deficiency DiseaseUnited States
-
Instituto Grifols, S.A.CompletedCoronary Artery Bypass | Acquired Antithrombin III DeficiencyItaly
-
Instituto Grifols, S.A.CompletedTarget Bleeding Site During Peripheral Vascular SurgeryCanada, United Kingdom, Spain
-
Instituto Grifols, S.A.Completed
-
Mayo ClinicGrifols Biologicals, LLCWithdrawnStiff-Person SyndromeUnited States
-
Duke UniversityGrifols Biologicals, LLCCompletedATIII DeficiencyUnited States
-
University Hospital, LilleGrifols Biologicals, LLCCompletedAutoimmune DiseasesFrance
-
University of WashingtonGrifols Biologicals, LLCWithdrawnImmune-Mediated Necrotizing MyopathyUnited States
-
Children's Hospital Los AngelesGrifols Biologicals, LLCActive, not recruitingHemophilia A | Immune ToleranceUnited States
-
Vanderbilt UniversityDuke University; Grifols Biologicals, LLCCompletedThoracic Surgery
-
The Methodist Hospital Research InstituteGrifols Biologicals, LLCCompletedRabies | Rabies Human | Rabies Virus InfectionUnited States
-
Enrique GinzburgGrifols Biologicals, LLCTerminatedCovid19 | Antithrombin III DeficiencyUnited States
-
University of California, San DiegoGrifols Biologicals, LLCCompletedFluid Overload | Hypotension During Dialysis
-
The Methodist Hospital Research InstituteGrifols Biologicals, LLCRecruitingRabies | Rabies Human | Pediatrics | Rabies Virus InfectionUnited States
-
Beth Israel Deaconess Medical CenterGrifols Biologicals, LLCTerminatedDiabetes Mellitus | Diabetes Complications | Diabetic NeuropathiesUnited States
-
Children's Hospital Medical Center, CincinnatiGrifols Biologicals, LLCCompletedCardiopulmonary Bypass | Extracorporeal Membrane Oxygenation ComplicationUnited States
-
University of Alabama at BirminghamGrifols Biologicals, LLCCompletedCongenital Heart Disease | HypogammaglobulinemiaUnited States
-
Grifols Therapeutics LLCInstituto Grifols, S.A.RecruitingAcute-On-Chronic Liver FailureUnited States, United Kingdom, Spain, Germany, Italy, Belgium, France, Austria, Denmark, Portugal
-
Grifols Therapeutics LLCGrifols Japan K.K.CompletedAlpha1-Antitrypsin DeficiencyJapan
-
Grifols Therapeutics LLCInstituto Grifols, S.A.CompletedCongenital AfibrinogenemiaIndia, United States, Italy, Lebanon
-
Rachael CusackGrifols Biologicals, LLCRecruitingSepsis | Septic Shock | Sepsis, SevereIreland
-
Ottawa Hospital Research InstituteCSL Behring; Grifols Biologicals, LLCCompleted
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencySpain, France, Germany, United Kingdom, Australia, Czechia, Hungary, Poland, Sweden
-
Grifols Therapeutics LLCWithdrawnPrimary ImmunodeficiencyUnited States
-
Grifols Therapeutics LLCCompletedMyasthenia GravisUnited States, Belgium, Czechia, Estonia, Canada, France, Germany, Hungary, Poland, Lithuania
-
Grifols Therapeutics LLCCompletedPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedAcute Ischemic StrokeSpain, Australia, France, Austria, Serbia, Slovakia
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompleted
-
Grifols Therapeutics LLCCompletedEmphysema | Alpha 1-antitrypsin Deficiency (AATD)United States
-
Grifols Therapeutics LLCCompletedCommon Variable Immunodeficiency | Severe Combined Immunodeficiency | Wiskott-Aldrich Syndrome | Agammaglobulinemia | Immunologic Deficiency SyndromeCanada, United States